U.C. Berkeley Researcher Proposes 340B Be Limited to the Indigent or that Providers Pass on their Discounts to Insurance Industry

Dr. James Robinson, a health economist at University of California at Berkley, criticized hospitals’ “buy and bill” drug acquisition process.
A University of California at Berkeley academic is proposing a series of major reforms to the 340B discount drug program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Long-Awaited Federal Bill to Protect Contract Pharmacy Arrangements Introduced

Doris Matsui
Rep. Doris Matsui (D-Calif.) introduced federal legislation to prohibit drugmaker 340B contract pharmacy restrictions.
Long-awaited federal legislation to bar drugmaker restrictions on 340B contract pharmacy arrangements was introduced today. The Mar 12 bill sponsored [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Is Thirty-first Company to Implement Contract Pharmacy Restrictions

Genentech building
Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.
Drugmaker Genentech has given some 340B hospitals advance notice of its plan to implement contract pharmacy restrictions. The biotech giant, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Biden Budget Request Keeps OPA Funding Flat

President Joe Biden's fiscal year 2025 budget would increase HRSA funding but not the budget of OPA, the office that oversees the 340B program.
Despite the looming finalization of a major policy change, this week’s fiscal year 2025 budget request would freeze the budget [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Conservative Media Campaign Continues, Hospital Group Demands Removal of Ads Linking 340B to Illegal Immigration

A 340B hospital trade group demanded local stations remove a dark money ad that links the 340B program to immigration growth.
A national hospital advocacy group “insists” multiple television stations remove a dark money group’s political ads alleging federal funding for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Massachusetts to Bar Managed Medicaid Payments for GLP-1 Drugs for 340B Patients

MassHealth, the Massachusetts Medicaid program, will soon bar managed care plans for paying for certain high-cost obesity drugs using 340B.
Massachusetts will soon change its Medicaid payment policy to bar managed care plans from paying for seven high-cost, anti-obesity medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Offers 10 Years of Refunds on High-Selling Drug, Multi-Year on Another; Merck to Give Single-Quarter Refunds

Genentech building
Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.
Drugmaker Genentech announced multi-year refunds to 340B providers on past purchases of two separate high-selling drugs, while Merck offered a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

CMS Directs Contractors to Provide Accelerated Payments as Part of Change Healthcare Cyber Attack Response

CMS
In response to the ongoing Change Healthcare cyberattack, CMS will direct contractors to provide some accelerated payments to hospitals.
The Centers for Medicare & Medicaid Services (CMS) will direct Medicare administrative contractors (MACs) to provide some accelerated payments to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Dark Money Group Ominously Warns That 340B Used to ‘Launder Your Money,’ Contributes to Immigration Crisis

A 340B hospital trade group demanded local stations remove a dark money ad that links the 340B program to immigration spending.
Building America’s Future, a nonprofit advocacy group that previously focused on trade, infrastructure, and tobacco issues, recently pushed into drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Liquidia Becomes 30th Manufacturer to Limit Access to 340B Pricing in Contract Pharmacy Setting

Liquidia recently became the 30th drug manufacturer to restrict access to 340B pricing in the contract pharmacy setting.
Drugmaker Liquidia will implement contract pharmacy restrictions for a single drug that has a still-pending new drug application (NDA). The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live